Back to results
US 12,648,958 B2Granted
TREM compositions and uses thereof
AssigneeFlagship Pioneering Innovations VI, LLC
InventorsTheonie Anastassiadis, David Charles Donnell Butler, Neil Kubica, Qingyi Li
Life of this patent
Estimating the term…
Abstract
The invention relates generally to tRNA-based effector molecules having a non-naturally occurring modification and methods relating thereto.
Claims14
A tRNA-based effector molecule (TREM) comprising a non-naturally occurring modification at a nucleotide position corresponding to a selected nucleotide position of a reference sequence, wherein:
- (i) the reference sequence is SEQ ID NO:
- 622, and the selected nucleotide position is selected from nucleotide positions 2, 3, and 73 of SEQ ID NO:
- 622;
- (ii) the non-naturally occurring modification is selected from an internucleotide modification and a 2′-modification on a nucleotide sugar moiety;
- (iii) the TREM comprises at least 73 nucleotides;
- and
- (iv) the TREM is capable of mediating acceptance of an amino acid or transfer of the amino acid in the initiation or elongation of a polypeptide chain.
4 more elements
Dependencies are inferred from the claim text.